SELEGILINE AS AN ADJUNCT TO CONVENTIONAL LEVODOPA THERAPY IN PARKINSONS-DISEASE - EXPERIENCE WITH THIS TYPE-B MONOAMINE-OXIDASE INHIBITOR IN 200 PATIENTS

被引：37

作者：

ELIZAN, TS ^{[1
]}

YAHR, MD ^{[1
]}

MOROS, DA ^{[1
]}

MENDOZA, MR ^{[1
]}

PANG, S ^{[1
]}

BODIAN, CA ^{[1
]}

机构：

[1] CUNY,MT SINAI MED CTR,DEPT BIOMATH SCI,NEW YORK,NY 10029

来源：

ARCHIVES OF NEUROLOGY | 1989年 / 46卷 / 12期

关键词：

D O I：

10.1001/archneur.1989.00520480022013

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：1280 / 1283

页数：4

共 30 条

[21] MONOAMINE-OXIDASE ACTIVITY AND MONOAMINE METABOLISM IN BRAINS OF PARKINSONIAN-PATIENTS TREATED WITH L-DEPRENYL [J].

RIEDERER, P ;

YOUDIM, MBH .

JOURNAL OF NEUROCHEMISTRY, 1986, 46 (05) :1359-1365

[22] L-DEPRENYL TREATMENT OF ON-OFF PHENOMENA IN PARKINSONS-DISEASE [J].

RINNE, UK ;

SIIRTOLA, T ;

SONNINEN, V .

JOURNAL OF NEURAL TRANSMISSION, 1978, 43 (3-4) :253-262

[23] DEPRENYL (SELEGILINE) IN THE TREATMENT OF PARKINSONS-DISEASE [J].

RINNE, UK .

ACTA NEUROLOGICA SCANDINAVICA, 1983, 68 :107-111

[24] CLINICAL AND PHARMACOLOGICAL PROBLEMS OF DEPRENYL (SELEGILINE) TREATMENT IN PARKINSONS-DISEASE [J].

STERN, GM ;

LEES, AJ ;

HARDIE, RJ ;

SANDLER, M .

ACTA NEUROLOGICA SCANDINAVICA, 1983, 68 :113-116

[25]

STREIFLER M, 1980, CURR THER RES CLIN E, V27, P643

[26] OVERVIEW OF PRESENT-DAY TREATMENT OF PARKINSONS-DISEASE [J].

YAHR, MD .

JOURNAL OF NEURAL TRANSMISSION, 1978, 43 (3-4) :227-238

[27] TREATMENT OF PARKINSONS-DISEASE IN EARLY AND LATE PHASES - USE OF PHARMACOLOGICAL AGENTS WITH SPECIAL REFERENCE TO DEPRENYL (SELEGILINE) [J].

YAHR, MD ;

MENDOZA, MR ;

MOROS, D ;

BERGMANN, KJ .

ACTA NEUROLOGICA SCANDINAVICA, 1983, 68 :95-102

[28]

YAHR MD, 1975, ADV PARKINSONISM, P435

[29] HUMAN BRAIN MONOAMINE-OXIDASE - MULTIPLE FORMS AND SELECTIVE INHIBITORS [J].

YOUDIM, MBH ;

SANDLER, M ;

BEVANJON.AB ;

NICHOLSON, WJ ;

PARE, CMB ;

COLLINS, GGS .

NATURE, 1972, 236 (5344) :225-+

[30]

ZSILLA G, 1986, POL J PHARMACOL PHAR, V38, P57

← 1 2 3 →